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Purpose: To evaluate the association of Toll-like receptor 4 (TLR4) gene polymorphisms with normal tension glaucoma
(NTG) in the South Korean population.
Methods: A total of 147 normal tension glaucoma patients in South Korea were recruited from April, 2007 to August,
2008. Allele, genotype, and haplotype of 8 different types of TLR4 single nucleotide polymorphisms were analyzed:
rs10759930, rs1927914, rs1927911, rs12377632, rs2149356, rs11536889, rs7037117, and rs7045953. Three hundred
eighty healthy, unrelated South Korean adults were enrolled as controls.
Results: Frequencies of the TLR4 allele did not show any statistically significant difference between normal tension
glaucoma patients and the control group (p>0.00625). The same results were observed in genotype frequency analysis.
In addition, no statistically significant difference was observed in the frequency of haplotypes in cases of normal tension
glaucoma when compared with controls.
Conclusions: TLR4 single nucleotide polymorphisms are not associated with normal tension glaucoma. Findings from
this study suggest that TLR4 polymorphisms may not play an important role in NTG pathogenesis in the South Korean
population.
In the study of glaucoma, molecular genetics is still a
challenging technology, but it aids in the determination of the
etiology of the disease and points toward an understanding of
its pathophysiology, ultimately allowing for its prevention and
cure. In previous studies, genetic loci and responsible genes
associated with various glaucomas have been identified: the
trabecular meshwork glaucocorticoid response gene (TIGR/
myocillin)  in  chromosome  1q23–25  is  associated  with
juvenile-onset open angle glaucoma, the gene in chromosome
7q36 with pigment dispersion syndrome, and the cytochrome
P4501B1 (CYP1B1) gene in chromosome 2p21 with primary
congenital  glaucoma  [1].  Adult-onset  chronic  open  angle
glaucoma, the most common type of glaucoma, has also been
reported to show strong evidence for genetic heterogeneity,
and at least 11 genetic loci, along with 3 genes (myocilin,
optineurin, and WD repeat domain 36 gene [WDR36]), have
been identified [1].
A recent study reported that average intraocular pressure
in an ophthalmologically normal Japanese population was
14.5 mmHg, lower than the value for Western countries, and
prevalence of normal tension glaucoma was 92%, higher than
that  of  other  countries  [2,3].  The  Namil  study,  an
epidemiology study in South Korea, also reported that the
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prevalence of primary open angle glaucoma was 3.9%, and in
80% of the population studied, the intraocular pressure was
21 mmHg or less [4]. These results implicate the influence of
genetic  background  and/or  environmental  exposure  in  the
development of normal tension glaucoma (NTG). Regarding
genetic aspects, polymorphisms in the optic atrophy type 1
gene have been associated with NTG in some cases,
and optineurin, which is in the one locus (GLC1E), has also
been associated with a small fraction of cases of NTG [5,6].
Optineurin protein may function to protect the optic nerve
from tissue necrosis factor α–mediated apoptosis, and loss of
function  of  this  protein  may  decrease  the  threshold  for
ganglion  cell  apoptosis  in  patients  with  glaucoma  [7].  In
addition, E50K mutations in optineurin, although rare, have
contributed  to  a  severe  form  of  NTG,  and  studies  of
lymphocytes  have  demonstrated  altered  expression  of  the
p53 gene, a known regulator of apoptosis [8,9].
Recently, Shibuya et al. [10] suggested an association of
multiple single nucleotide polymorphisms (SNPs) in Toll-like
receptor 4 (TLR4) with a risk of NTG, and the ligands and/or
cytokines involved in the TLR4 signaling network may be risk
factors for the development of NTG. TLRs recognize both
endogenous  and  exogenous  molecules  [11].  Arbour  et  al.
[12] reported a close relationship between D299G, the non-
synonymous  change  of  the  TLR4  gene,  and  endotoxin
hyporesponsiveness;  its  association  with  atherosclerosis,
Crohn’s  disease,  and  ulcerative  colitis  was  also  reported
[12-14]. In the opththalmologic field, heat shock protein andlipopolysaccharide  (LPS)  were  previously  suggested  as
potential candidates for NTG antigens, and the TLR protein
was  known  to  recognize  these  [11].  C3H/HeJ  mice  with
TLR4 mutations showed glaucomatous optic nerve change in
addition to defects of the LPS signaling pathway [15]. Despite
this evidence, the role of TLR4 as one of the risk factors for
NTG development is still unknown. To this end, we have
evaluated  the  association  of  TLR4  polymorphisms  with
normal  tension  glaucoma  and  further  investigated  the
phenotype-genotype correlation.
METHODS
Subjects: One hundred forty-seven unrelated South Korean
patients with NTG were recruited. The criteria applied for
diagnosis of NTG were as follows: presence of glaucomatous
optic neuropathy with compatible glaucomatous visual field
defects on Humphrey 30–2 standard automated perimetry in
association with an open angle on gonioscopy, and intraocular
pressure (IOP) below 24 mmHg by Goldmann applanation
tonometry without anti-glaucoma medication. A visual field
test was considered abnormal if 2 of the following 3 criteria
were  met  on  at  least  2  consecutive  examinations  with
acceptable reliability standards (fixation loss <20%, false-
positive rate <33%, and false-negative rate <33%): (1) an
abnormal glaucoma hemifield test result (borderline findings
were not considered abnormal), (2) at least 3 contiguous non-
edge points (allowing 2 nasal step edge points) with p<0.05
on the pattern standard deviation plot and at least 1 point with
p<0.01, and (3) a corrected pattern standard deviation with
p<0.05.  The  location  and  pattern  of  the  defect  had  to  be
consistent  between  the  2  consecutive  visual  field
examinations, and the glaucomatous optic disc damage had to
be consistent with the visual field abnormality. For inclusion
in this study, patients were required to have untreated IOP
readings of 24 mmHg or lower at all times, as measured by
glaucoma specialists. Patients were excluded if they had a
history of angle closure, ocular trauma, corneal opacity, laser
iridotomy, inflammatory eye disease, non-glaucomatous optic
neuropathy  or  other  neuro-ophthalmic  disease,  or  ocular
surgery. Patients with pseudoexfoliation, pigment dispersion,
consistently  unreliable  visual  field  tests,  or  best-corrected
visual  acuity  of  less  than  20/40  were  also  excluded.  All
patients were followed long-term to ensure diagnosis of NTG.
Three hundred eighty unrelated healthy South Koreans
who did not have glaucoma and family history of glaucoma
were enrolled as the control group. They were all of Korean
ethnicity, age- and sex-matched, and with no consanguineous
marriage. A diagnosis of glaucoma was ruled out through
examination of IOP and optic disc in all members of the
control group. The study was conducted in compliance with
the tenets of the Declaration of Helsinki for the use of human
subjects in biomedical research, and institutional review board
approval  was  obtained.  Written  informed  consent  was
obtained from all study subjects.
TLR4 analysis: Genomic DNA was extracted from leukocytes
of  peripheral  blood,  and  eight  single  nucleotide
polymorphisms (SNPs; rs10759930, rs1927914, rs1927911,
rs12377632,  rs2149356,  rs11536889,  rs7037117,  and
rs7045953) of TLR4 were investigated in all NTG cases and
control groups. Genotyping of SNPs was performed using the
5′  exonuclease  assay  (TaqMan:  Applied  Biosystem,  Inc.
[ABI], Foster City, CA). The fluorescence signal of the probe
was  detected  with  Real-time  Polymerase  chain  reaction
(TaqMan assay for Real Time PCR [RT–PCR], 7000 Real
Time PCR Systems; ABI).
Phenotype analysis: Demographic data for all NTG patients
were reviewed: age, sex, refractive errors, central corneal
thickness  using  a  contact-type  ultrasound  pachymeter
(IOPac®,  Heidelberg  engineering,  Heidelberg,  Germany),
underlying systemic disease, current medication, and follow-
up  periods.  Baseline  intraocular  pressure  by  Goldmann
applanation  tonometry  without  anti-glaucoma  medication,
response of intraocular pressure to anti-glaucoma medication,
and types and numbers of anti-glaucoma medication were also
recorded. Mean deviation and pattern standard deviation in
Humphrey 30–2 standard automated perimetry, presence of
visual field progression, and changes in optic disc and retinal
nerve fiber layer were also recorded.
Statistical  analysis:  PASW  software  (version  17.0,  SPSS,
Inc., Chicago, IL) was used for statistical analyses. Call rates
of the control and NTG groups were calculated. All SNPs
among cases and control groups were assessed for Hardy–
Weinberg  equilibrium  using  a  χ2  test.  To  examine  the
association, we used χ2 tests or Fisher exact tests (if needed)
for  comparison  of  the  allele  frequencies,  genotype
frequencies, and haplotypes. In the genotype trend analysis,
we  evaluated  any  change  in  frequency,  depending  on  the
change in the genotype. In the genotype dominance model,
the frequencies of the dominant genotype were compared with
other types of genotypes, and, in the recessive model, the
frequencies of the minor genotype were compared with other
extra  types.  To  correct  for  multiple  testing  bias,  10,000
permutations  for  computation  of  p  with  the  Haploview
program were used. The program Haploview 3.32 was used
for  the  computation  of  pair-wise  linkage  disequilibrium
statistics, and D’ values expressed in percentages were plotted
[16].  Haplotype  frequencies  were  estimated  using  a
previously mentioned accelerated expectation-maximization
algorithm [17]. A p-value of less than 0.05 was considered
statistically  significant  and  Bonferroni’s  correction  was
applied for multiple tests.
RESULTS
When  eight  SNPs  in  TLR4  were  genotyped,  genotype
distributions of all SNPs in the controls and the NTG cases
exhibited  Hardy–Weinberg  equilibrium,  and  call  rates  of
controls and NTG patients were all 100% (Table 1). Allele
frequencies of the 5 SNPs in cases and controls are listed in
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lower than those of controls, except for rs11536889 (Table 2).
Evaluation  using  Bonferroni’s  correction  found  no
statistically  significant  association  with  any  of  the  SNPs
between NTG cases and controls (p>0.05/8=0.00625).
Genotype frequencies of the 8 SNPs are shown in Table
3 and Table 4. Genotype trend analysis showed no statistically
significant  difference  between  controls  and  NTG  patients
(p>0.00625). In the analyses with the minor allele dominance
model and the minor allele recessive model, none of the SNPs
showed a statistically significant association between the two
groups (p>0.00625). In a comparison of the frequencies in
each  genotype,  no  statistically  significant  association  was
found in any of the 8 SNPs (p>0.00625).
All 8 SNPs were located in 1 haplotype block, and the
magnitude of linkage disequilibrium between each SNP was
TABLE 1. HARDY–WEINBERG EQUILIBRIUM TEST.
  p Call rate
SNPs Controls Cases Total Controls Cases Total
rs10759930 0.511 0.815 0.498 1 1 1
rs1927914 0.435 0.815 0.433 1 1 1
rs1927911 0.519 0.923 0.550 1 1 1
rs12377632 0.488 0.968 0.573 1 1 1
rs2149356 0.464 0.968 0.550 1 1 1
rs11536889 0.758 0.320 0.431 1 1 1
rs7037117 0.791 0.392 0.501 1 1 1
rs7045953 0.121 0.208 0.048 1 1 1
          SNPs: single nucleotide polymorphisms; p: E\ χ2 test.
TABLE 2. ALLELE FREQUENCIES OF SNPS OF TLR4 ANALYSIS.
    Minor allele
frequency (%)
       
SNPs Alleles (1/2) Controls Cases p pc pf OR (95% CI)
rs10759930 T/C 41.7 40.1 0.641 0.781 0.675 0.93 (0.70–1.24)
rs1927914 A/G 41.5 40.1 0.669 0.88 0.676 0.94 (0.70–1.25)
rs1927911 G/A 41.0 39.7 0.709 0.974 0.727 0.94 (0.71–1.26)
rs12377632 C/T 41.4 39.4 0.555 0.983 0.576 0.92 (0.69–1.22)
rs2149356 G/T 41.1 39.4 0.608 0.986 0.625 0.93 (0.69–1.23)
rs11536889 G/C 23.5 26.5 0.312 0.988 0.337 1.17 (0.84–1.61)
rs7037117 A/G 25.6 24.8 0.781 0.992 0.813 0.95 (0.69–1.31)
rs7045953 A/G 9.47 7.82 0.401 0.999 0.472 0.81 (0.47–1.34)
        SNPs: single nucleotide polymorphisms; p: by χ2 test; pc: corrected p-value using 10,000 permutations; pf: by Fisher-exact test;
        OR: odds ratio; CI: confidence interval.
TABLE 3. GENOTYPE FREQUENCIES OF SNPS OF TLR4 ANALYSIS I.
    Genotype frequency (n)     
    Cases                                                Controls    
SNPs Alleles (1/2) 1/1 1/2 2/2 1/1 1/2 2/2 p pf
rs10759930 T/C 52 72 23 126 191 63 0.884 0.913
rs1927914 A/G 52 72 23 126 192 62 0.889 0.889
rs1927911 G/A 53 71 23 129 190 61 0.900 0.897
rs12377632 C/T 54 70 23 127 191 62 0.771 0.777
rs2149356 G/T 54 70 23 128 191 61 0.800 0.804
rs11536889 G/C 77 62 8 221 139 20 0.471 0.464
rs7037117 A/G 85 51 11 211 143 26 0.814 0.820
rs7045953 A/G 126 19 2 314 60 6 0.692 0.744
          SNPs: single nucleotide polymorphisms; p: by χ2 test; pf: by Fisher-exact test.
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frequencies are listed in Table 5. Frequencies of haplotypes
TAGCGCA and CGATTCA were lower in NTG cases when
compared  with  those  of  the  controls.  However,  when
evaluated using Bonferroni’s correction, this difference did
not  show  statistical  significance.  No  other  significant
differences in other haplotype frequencies between cases and
controls were detected.
DISCUSSION
Recognition of pathogens is mediated by a set of germline-
encoded  receptors,  referred  to  as  pattern-recognition
receptors,  and  TLRs  function  as  the  pattern-recognition
receptors in humans [18]. TLRs are related to both innate
immunity and adaptive immunity through the recognition of
microbial components and the induction of the production of
cytokines, such as Interleukin 12 and Interleukin 18, driving
the differentiation of T-cells [18]. Ten members of TLR have
been reported, and TLR genes are dispersed throughout the
genome;  those  encoding  TLR1  and  TLR4  map  to  human
chromosome 4p14, TLR2 and TLR3 to 4q31.3-q35, TLR4 to
9q32-q33, TLR5 to 1q33.3-q42, TLR7 and TLR8 to XP 22
[18]. In particular, TLR4 recognizes the entirely unrelated
ligands LPS, heat shock proteins 60 and Taxol. Among these,
an association of LPS and heat shock proteins with glaucoma
has been previously reported [11]. With regard to NTG, a
recent study reported on an association of multiple SNPs in
TLR4 with the risk of NTG in the Japanese population [10].
The  minor  allele  of  3  SNPs  (rs10759930,rs1927914,  and
rs7037117) increased the risk of NTG and the minor allele of
6  SNPs
(rs10759930,rs1927914,rs1927911,rs12377632,rs2149356,
and rs7037117) had a 1.47 to 1.65 fold increased risk of NTG
[10]. In addition, a strong association with rs7037117 was
reported [10].
We  attempted  to  determine  whether  there  were  any
associations  between  TLR4  polymorphisms  and  normal
tension glaucoma in the South Korean population, and we
Figure 1. Linkage disequilibrium plot of 8 SNPs of TLR4 in NTG
patients and controls.
TABLE 4. GENOTYPE FREQUENCIES OF SNPS OF TLR4 ANALYSIS II.
 
Major versus hetero genotype Major versus minor genotype
SNPs pf OR (95% CI) pf OR (95% CI) pt
rs10759930 0.746 0.913 (0.587–1.426) 0.771 0.885 (0.472–1.626) 0.636
rs1927914 0.667 0.908 (0.584–1.419) 0.771 0.899 (0.479–1.654) 0.664
rs1927911 0.668 0.909 (0.585–1.418) 0.884 0.917 (0.489–1.687) 0.704
rs12377632 0.519 0.862 (0.554–1.343) 0.666 0.872 (0.466–1.601) 0.550
rs2149356 0.520 0.869 (0.559–1.353) 0.771 0.894 (0.477–1.641) 0.603
rs11536889 0.223 1.279 (0.843–1.937) 0.822 1.147 (0.419–2.857) 0.304
rs7037117 0.606 0.885 (0.575–1.354) 1 1.050 (0.447–2.318) 0.784
rs7045953 0.495 0.789 (0.426–1.406) 1 0.831 (0.080–4.727) 0.420
 
Minor allele dominance model Minor allele recessive model
 
SNPs pf OR (95% CI) pf OR (95% CI)  
rs10759930 0.681 0.906 (0.597–1.383) 0.895 0.933 (0.528–1.605)  
rs1927914 0.681 0.906 (0.597–1.383) 0.895 0.951(0.537–1.638)  
rs1927911 0.683 0.911 (0.601–1.388) 1 0.970 (0.547–1.672)  
rs12377632 0.475 0.864 (0.571–1.315) 0.895 0.951 (0.537–1.638)  
rs2149356 0.540 0.875 (0.578–1.331) 1 0.970 (0.547–1.672)  
rs11536889 0.240 1.263 (0.845–1.885) 1 1.035 (0.385–2.525)  
rs7037117 0.695 0.910 (0.607–1.361) 0.849 1.101 (0.477 −2.382)  
rs7045953 0.434 0.793 (0.441–1.379) 1 0.860 (0.083–4.880)  
         SNPs: single nucleotide polymorphisms; p: by χ2 test; pf: by Fisher-exact test; pt: trend of genotype by χ2 test; OR: odds ratio;
         CI: confidence interval.
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correlation  in  NTG  patients  according  to  TLR4  SNPs.
However, our study did not show any association of TLR4
SNPs  with  risk  for  NTG.  There  were  some  possible
explanations for this contradictory result. One is the difference
between study subjects. In our study, criteria for IOP in NTG
patients was defined as 24 mmHg, whereas in the previous
study it was defined as 21 mmHg with Goldmann applanation
tonometry  without  anti-glaucoma  medication.  Also,  the
previous study group limited the range age of NTG cases as
≤20 years or ≥60 years; however, we only limited the lowest
level of age to include adult-onset open angle glaucoma. The
previous study focused on cases with a comparatively early
onset, because early onset suggests stronger involvement of
genetic factors, as the study authors mentioned. However, we
did  not  focus  on  early-onset  NTG,  since  we  planned  to
investigate the general risk for NTG patients, regardless of
age.  There  was  also  a  difference  in  the  number  of  study
participants. The Japanese study included 255 NTG cases and
318 healthy individuals, while 147 patients with NTG and 380
healthy controls were recruited in our study group. Selection
criteria for the controls in the two study groups were also
different, in that control individuals in our study were age- and
sex-matched, whereas controls in the Japanese group were
only age-matched.
In addition to the differences in study design between the
two studies, interestingly, minor allele frequencies in control
subjects in our study differed from those in the Japanese study,
though  statistical  analysis  was  not  performed  (Table  2).
Except for rs7037117, frequencies of minor alleles of controls
in the Japanese group were lower than those of our study
results. Furthermore, there was also a difference in genotype
frequencies in controls between the two populations (Table 3,
Table 4, and Table 5). These differences in the control group
may have influenced the study results. Adult-onset forms of
glaucoma, particularly normal tension glaucoma, are inherited
as complex traits, which is likely not inherited as a single gene.
Thus, different environmental factors, including ethnicity in
two populations or their genetic backgrounds, involving the
interference  of  multiple  genes,  may  have  influenced  the
results.
In the beginning of the study, we planned to evaluate the
genotype-phenotype correlation in NTG patients. Following
Wiggs, we had three research questions in mind: (1) What is
the range of phenotypic variation of a given mutation, i.e., can
one predict the prognosis of the disease knowing the specific
mutation  responsible  for  the  disease?;  (2)  Are  certain
mutations associated with particular aspects of the disease
phenotype?; and (3) Are certain mutations necessary but not
sufficient to cause the disease [19]. However, because there
were no statistically significant associations between TLR4
SNPs and NTG, we did not investigate further the aspects of
the relationship between NTG phenotype and TLR4 SNPs.
In conclusion, TLR4 single nucleotide polymorphisms
are not associated with normal tension glaucoma. This result
suggests that TLR4 polymorphisms may not play an important
role in NTG pathogenesis in the South Korean population. A
few studies have been conducted for identification of the
genetic risk, especially TLR4 SNPs, as a possible risk factor
of NTG. Although we considered genetic and environmental
variables, results differ between different groups of patients.
Thus,  further  studies  need  to  be  replicated  repeatedly  to
confirm the association of TLR4 SNPs and normal tension
glaucoma.  Moreover,  we  still  do  not  know  how  TLRs
recognize entirely unrelated ligands, and how this functions
in  human  cells.  Thus,  a  more  basic  molecular  biologic
approach to TLRs will be needed in the future.
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